Oxygenation of ω-3 fatty acids by human cytochrome P450 4F3B: Effect on 20-hydroxyeicosatetraenoic acid production

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 75, Issue 3, 2006, Pages 169-177

  Harmon, Shawn D ^a   Fang, Xiang ^a   Kaduce, Terry L ^a   Hu, Shanming ^a   Raj Gopal, V ^b   Falck, John R ^b   Spector, Arthur A ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; CARBON; CYTOCHROME P450 4F3B; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LUCIFERASE; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; ENZYME ACTIVITY; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY;

ANIMALS; ARACHIDONIC ACID; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COS CELLS; CYTOCHROME P-450 ENZYME SYSTEM; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; LIPID METABOLISM; MASS SPECTROMETRY; OXIDATION-REDUCTION; OXYGEN; RECOMBINANT PROTEINS;

EID: 33747874459     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2006.05.005     Document Type: Article

References (49)

1. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol. Rev. 82 (2002) 131-185
2. Kroetz D.L., and Zeldin D.C. Cytochrome P450 pathways of arachidonic acid metabolism. Curr. Opin. Lipidol. 13 (2002) 273-278
3. McGiff J.C., and Quilley J. 20-HETE and the kidney: resolution of old problems and new beginnings. Am. J. Physiol. 277 (1999) R607-R623
4. Capdevila J.H., Falck J.R., and Harris R.C. Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J. Lipid Res. 41 (2000) 163-181
5. Lasker J.M., Chen W.B., Wolf I., Bloswick B.P., Wilson P.D., and Powell P.K. Formation of 20-hydroxyeicosatetraenoic acid, a vascular and naturetic eicosanoid, in human kidney, role of CYP4F2 and CYP4A11. J. Biol. Chem. 275 (2000) 4118-4126
6. Muthalif M.M., Karzoun N.A., Gaber L., Khandekar Z., Benter I.F., Saeed A.E., Parmentier L.H., Estes A., and Malik K.U. Angiotensin II-induced hypertension: contribution of Ras GTPase/mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension 36 (2000) 604-609
7. Maier K.G., and Roman R.J. Cytochrome P450 metabolites of arachidonic acid in the control of renal function. Curr. Opin. Nephrol. Hypertens. 10 (2001) 81-87
8. Zhang F., Wang M.H., Krishna U.M., Falck J.R., Laniado-Schwartzman M., and Nasjletti A. Modulation by 20-HETE of phenylephrine-induced mesenteric artery contraction in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 38 (2001) 1311-1315
9. Moreno C., Maier K.G., Hoagland K.M., Yu M., and Roman R.J. Abnormal pressure-natriuresis in hypertension: role of cytochrome P450 metabolites of arachidonic acid. Am. J. Hypertens. 14 (2001) 90S-97S
10. Christmas P., Jones J.P., Patten C.J., Rock D.A., Zheng Y., Cheng S.-M., Weber B.M., Carlesso N., Scadden D.T., Rettie A.E., and Soberman R.J. Alternate splicing determines the function of CYP4F3 by switching substrate specificity. J. Biol. Chem. 276 (2001) 38166-38172
11. Knapp H.R., and FitzGerald G.A. The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N. Engl. J. Med. 320 (1989) 1037-1043
12. Bønaa K.A., Bjerve K.S., Straume B., Gram I.T., and Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromsø study. N. Engl. J. Med. 322 (1990) 795-801
13. Dyerberg J., Bang H.O., Stofferson E., Moncada S., and Vane J.R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis. Lancet ii (1978) 117-119
14. 3 and icosapentaenoic acid as potential anti-thrombotic substances. Proc. Natl. Acad. Sci. USA. 76 (1979) 5919-5923
15. Needleman P., Whitaker M.O., Wyche A., Watters K., Sprecher H., and Raz K. Manipulation of platelet aggregation by prostaglandins and their fatty acid precursors: pharmacologic basis for a therapeutic approach. Prostaglandins 19 (1980) 165-181
16. Yerram N.R., Moore S.A., and Spector A.A. Eicosapentaenoic acid metabolism in brain microvessel endothelium: effect on prostaglandin formation. J. Lipid Res. 30 (1989) 1747-1757
17. Hadjiagapiou C., and Spector A.A. Docosahexaenoic acid metabolism and effect on prostacyclin production in endothelial cells. Arch. Biochem. Biophys. 253 (1987) 1-12
18. Lee T.H., Hoover R.L., Williams J.D., Sperling R.I., Ravelese J., Spur B.W., Robinson D.R., Corey E.J., Lewis R.A., and Austin K.F. Effects of dietary enrichment with eicosapentaenoic and docosahexaenoic acid on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med. 312 (1985) 1217-1224
19. Lokesh B.R., Black J.M., German J.B., and Kinsella J.E. Docosahexaenoic acid and other dietary unsaturated fatty acids suppress leukotriene synthesis by mouse peritoneal macrophages. Lipids 23 (1988) 968-978
20. Barbosa-Sicard E., Markovic M., Honeck H., Crist B., Muller D.N., and Schunck W.H. Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily. Biochem. Biophys. Res. Commun. 329 (2005) 1275-1281
21. Fissthaler B., Popp R., Kiss L., Potente M., Harder D.R., Fleming I., and Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401 (1999) 493-497
22. Schwarz D., Kisselev P., Eriksen S.S., Szklarz G.D., Chernogolov A., Honeck H., Schunck W.H., and Roots I. Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid. Biochem. Pharmacol. 67 (2004) 1445-1457
23. Zhang Y., Oltman C.L., Lu T., Lee H.-C., Dellsperger K.C., and VanRollins M. EET homologues potently dilate coronary microvessels and activate BK(Ca) channels. Am. J. Physiol. 280 (2001) H2430-H2440
24. Lauterbach B., Barbosa-Sicard E., Wang M.H., Honeck H., Kargel E., Theuer J., Schwartzman M.L., Haller H., Luft F.C., Gollasch M., and Schunck W.H. Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators. Hypertension 39 (2002) 609-613
25. Ye D., Zhang D., Oltman C., Dellsperger K., Lee H.-C., and VanRollins M. Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels. JPET 303 (2002) 768-776
26. Marcheselli V.L., Hong S., Lukiw W.J., Tian X.H., Gronert K., Musto A., Hardy M., Gimenez J.M., Chang N., Serhan C.N., and Bazan N.G. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278 (2003) 43807-43817
27. Fang X., Hu S., Watababe T., Weintraub N.L., Snyder G.D., Yao J., Liu Y., Shyy J.Y.L., Hammock B.D., and Spector A.A. Activation of peroxisome proliferator-activated receptor α by substituted urea-derived soluble epoxide hydrolase inhibitors. JPET 314 (2005) 260-270
28. Fang X., Hu S., Xu B., Snyder G.D., Harmon S., Yao J., Liu Y., Sangras B., Falck J.R., Weintraub N.L., and Spector A.A. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-α. Am. J. Physiol. 290 (2006) H55-H63
29. Kaduce T.L., Fang X., Harmon S.D., Oltman C.L., Dellsperger K.C., Teesch L.M., Gopal V.R., Falck J.R., Campbell W.B., Weintraub N.L., and Spector A.A. 20-Hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cells. J. Biol. Chem. 279 (2004) 2648-2656
30. Gopal V.R., Jagadeesh S.G., Reddy Y.K., Bandyopadhyay A., Capdevila J.H., and Falck J.R. A practical, stereospecific route to 18-, 19-, and 20-hydroxyeicosa-5(Z),8(Z),11(Z),14(Z)-tetraenoic acids (18-, 19-, and 20-HETEs). Tetrahedron Lett. 45 (2004) 2563-2565
31. Rice M.B., Whitehead S.L., Horvath C.M., Muchnij J.A., and Maleczka Jr. R.E. The regiochemical influence of oxo-substitution in palladium-mediated hydrostannations of 1-alkynes. Synthesis (2001) 1495-1504
32. Falck J.R., Bondlela M., Ye J., and Cho S.-D. A preparation of benzylic and allylic boronates: cross-coupling of aryl- and alkenylstannanes with bromomethylboronates. Tetrahedron Lett. 40 (1999) 5647-5650
33. Zou G., and Falck J.R. Suzuki-Miyaura cross-coupling of lithium n-alkylborates. Tetrahedron Lett. 42 (2001) 5817-5819
34. Forman B.M., Chen J., and Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc. Natl. Acid. Sci. USA. 94 (1997) 4312-4317
35. Collins X.H., Harmon S.D., Kaduce T.L., Berst K.B., Fang X., Moore S.A., Raju T.V., Falck J.R., Weintraub N.L., Duester G., Plapp B.V., and Spector A.A. ω-Oxidation of 20-hydroxyeicosatetraenoic acid in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4. J. Biol. Chem. 280 (2005) 33157-33164
36. Shak S., Reich N.O., Goldstein I.M., and Ortiz de Montellano P.R. Leukotriene B4 omega-hydroxylase in human polymorphonuclear leukocytes. J. Biol. Chem. 260 (1985) 13023-13028
37. Burger A., Clark J.E., Nishimoto M., Muerhoff A.S., Masters B.S., and Ortiz de Montellano P.R. Mechanism-based inhibitors of prostaglandin ω-hydroxylase: (R)- and (S)-12-hydroxy-16-heptadecynoic acid and 2,2-dimethyl-12-hydroxy-16-heptadecynoic acid. J. Med. Chem. 36 (1993) 1418-1424
38. Kauser K., Clark J.E., Masters B.S., Ortiz de Montellano P.R., Ma Y.H., Harder D.R., and Roman R.J. Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries. Circ. Res. 68 (1991) 1154-1163
39. Cowart L.A., Wei S., Hsu M.H., Johnson E.F., Krishna M.U., Falck J.R., and Capdevila J.H. The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferators-activator receptor ligands. J. Biol. Chem. 277 (2002) 35105-35112
40. Zhu D., Zhang C., Medhora M., and Jacobs E.R. CYP4A mRNA, protein, and product in rat lungs: novel localization in vascular endothelium. J. Appl. Physiol. 93 (2002) 330-337
41. Desvergne B., and Wahli W. Peroxisome proliferators-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 (1999) 649-688
42. Frøyland L., Madsen L., Vaagenes H., Totland G.R., Auwerx J., Kryyi H., Staels B., and Berge R.K. Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism. J. Lipid Res. 38 (1997) 1851-1858
43. Carroll M.A., Balazy M., Huang D.D., Rybalova S., Falck J.R., and McGiff J.C. Cytochrome P450-derived renal HETEs: storage and release. Kidney Int. 51 (1997) 1696-1702
44. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.W., Wisely G.B., Koble C.A., Devchand P., Wahli W., Willson T.M., Lenhard J.M., and Lehmann J.M. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl. Acad. Sci. USA. 94 (1997) 4318-4323
45. Hosteter H.A., Petrescu A.D., Kier A.B., and Schroeder F. Peroxisome proliferator-activated receptor α interacts with high affinity and is conformationally responsive to endogenous ligands. J. Biol. Chem. 280 (2005) 18667-18682
46. Fang X., Kaduce T.L., Weintraub N.L., VanRollins M., and Spector A.A. Functional implications of a newly characterized pathway of 11,12-epoxyeicosatrienoic acid metabolism in arterial smooth muscle. Circ. Res. 79 (1996) 784-793
47. Fang X., Kaduce T.L., Weintraub N.L., Harmon S., Teesch L.M., Morisseau C., Thompson D.A., Hammock B.D., and Spector A.A. Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells, Implications for the vascular effects of soluble epoxide hydrolase inhibition. J. Biol. Chem. 276 (2001) 14867-14874
48. Bocos C., Gottlicher M., Gearing K., Banner C., Enmark E., Teboul M., Crickmore A., and Gustafsson J.A. Fatty acid activation of peroxisome proliferator-activated receptor (PPAR). J. Steroid Biochem. Mol. Biol. 53 (1995) 467-473
49. Spector A.A. The transport and utilization of free fatty acid. Ann. NY Acad. Sci. 149 (1968) 768-783